Use of fenofibrate in the management of protease inhibitor-associated lipid abnormalities. [electronic resource]

By:

Thomas, J C

Contributor(s):

Lopes-Virella, M F
Del Bene, V E
Cerveny, J D
Taylor, K B
McWhorter, L S
Bultemeier, N C

Producer: 20000928Description: 727-34 p. digitalISSN:

0277-0008

Subject(s):

Adult
Cytochrome P-450 CYP3A
Cytochrome P-450 Enzyme System -- physiology
Female
Fenofibrate -- therapeutic use
HIV Protease Inhibitors -- adverse effects
Humans
Hypertriglyceridemia -- drug therapy
Hypolipidemic Agents -- therapeutic use
Lipoproteins, HDL -- blood
Male
Middle Aged
Mixed Function Oxygenases -- physiology

Online resources:

Available from publisher's website

In: Pharmacotherapy vol. 20

Tags from this library: No tags from this library for this title. Log in to add tags.

Star ratings

Cancel rating. Average rating: 0.0 (0 votes)

Holdings ( 0 )
Title notes ( 1 )
Comments ( 0 )

No physical items for this record

Publication Type: Case Reports; Journal Article

There are no comments on this title.

Browse results Close

Back to results

1 Doppler study of the fetal circulation during long-term maternal hyperoxygenation for severe early onset intrauterine growth retardation.
by Bilardo, C M
2 Accuracy in identifying the elbow rotation axis on simulated fluoroscopic images using a new anatomical landmark.
by Wiggers, J K
3 Relationship between fetal acidemia at cordocentesis and subsequent neurodevelopment.
by Soothill, P W

Use of fenofibrate in the management of protease inhibitor-associated lipid abnormalities.

APA

Thomas J. C., Lopes-Virella M. F., Del Bene V. E., Cerveny J. D., Taylor K. B., McWhorter L. S. & Bultemeier N. C. (20000928). Use of fenofibrate in the management of protease inhibitor-associated lipid abnormalities. : Pharmacotherapy.

Chicago

Thomas J C, Lopes-Virella M F, Del Bene V E, Cerveny J D, Taylor K B, McWhorter L S and Bultemeier N C. 20000928. Use of fenofibrate in the management of protease inhibitor-associated lipid abnormalities. : Pharmacotherapy.

Harvard

Thomas J. C., Lopes-Virella M. F., Del Bene V. E., Cerveny J. D., Taylor K. B., McWhorter L. S. and Bultemeier N. C. (20000928). Use of fenofibrate in the management of protease inhibitor-associated lipid abnormalities. : Pharmacotherapy.

MLA

Thomas J C, Lopes-Virella M F, Del Bene V E, Cerveny J D, Taylor K B, McWhorter L S and Bultemeier N C. Use of fenofibrate in the management of protease inhibitor-associated lipid abnormalities. : Pharmacotherapy. 20000928.

Print
Cite
Add to your cart (remove)
Save record
BIBTEX Dublin Core MARCXML MARC (non-Unicode/MARC-8) MARC (Unicode/UTF-8) MARC (Unicode/UTF-8, Standard) MODS (XML) RIS ISBD
More searches

Search for this title in:
Other Libraries (WorldCat) Other Databases (Google Scholar) Online Stores (Bookfinder.com) Open Library (openlibrary.org)

Exporting to Dublin Core...

Simple DC-RDF

OAI-DC

SRW-DC